While
inflammation is considered a central component in the development in
diabetic nephropathy, the mechanism remains unclear. The NLRP3
inflammasome acts as both a sensor and a regulator of the inflammatory response. The NLRP3
inflammasome responds to exogenous and endogenous danger signals, resulting in cleavage of
procaspase-1 and activation of
cytokines IL-1β,
IL-18, and
IL-33, ultimately triggering an inflammatory cascade reaction. This study observed the expression of NLRP3
inflammasome signaling stimulated by high
glucose,
lipopolysaccharide, and
reactive oxygen species (ROS) inhibitor
N-acetyl-L-cysteine in glomerular mesangial cells, aiming to elucidate the mechanism by which the NLRP3
inflammasome signaling pathway may contribute to
diabetic nephropathy. We found that the expression of
thioredoxin-interacting
protein (TXNIP), NLRP3, and IL-1β was observed by immunohistochemistry in vivo. Simultaneously, the
mRNA and
protein levels of TXNIP, NLRP3,
procaspase-1, and IL-1β were significantly induced by high
glucose concentration and
lipopolysaccharide in a dose-dependent and time-dependent manner in vitro. This induction by both high
glucose and
lipopolysaccharide was significantly inhibited by
N-acetyl-L-cysteine. Our results firstly reveal that high
glucose and
lipopolysaccharide activate ROS/TXNIP/ NLRP3/IL-1β
inflammasome signaling in glomerular mesangial cells, suggesting a mechanism by which
inflammation may contribute to the development of
diabetic nephropathy.